| 000 | 01350 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512235112.0 | ||
| 264 | 0 | _c19830811 | |
| 008 | 198308s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19830715)52:2<215::aid-cncr2820520206>3.0.co;2-f _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUnverferth, B J | |
| 245 | 0 | 0 |
_aEarly changes in human myocardial nuclei after doxorubicin. _h[electronic resource] |
| 260 |
_bCancer _cJul 1983 |
||
| 300 |
_a215-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAcetylcysteine _xpharmacology |
| 650 | 0 | 4 |
_aCardiomyopathies _xchemically induced |
| 650 | 0 | 4 |
_aCell Nucleolus _xdrug effects |
| 650 | 0 | 4 |
_aCell Nucleus _xdrug effects |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDoxorubicin _xadverse effects |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardium _xultrastructure |
| 700 | 1 | _aMagorien, R D | |
| 700 | 1 | _aBalcerzak, S P | |
| 700 | 1 | _aLeier, C V | |
| 700 | 1 | _aUnverferth, D V | |
| 773 | 0 |
_tCancer _gvol. 52 _gno. 2 _gp. 215-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19830715)52:2<215::aid-cncr2820520206>3.0.co;2-f _zAvailable from publisher's website |
| 999 |
_c6860801 _d6860801 |
||